Bio-Rad Laboratories Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.1% | 45.0% | 46.0% | 45.8% | 43.1% | 45.3% | 45.2% | 47.6% | 47.4% | 46.1% | 43.7% | 46.3% | 45.2% | 47.1% | 44.5% | 45.4% | 43.3% | 41.7% | 44.9% | 43.9% | 41.4% | 45.3% | 42.5% | 42.7% | 45.1% | 45.6% | 46.5% | 46.8% | 46.9% | 46.3% | 46.6% | 44.3% | 45.2% | 48.8% | 47.7% | 47.0% | 47.4% | 50.2% | 47.7% | 46.9% | 48.1% | |
| 54.9% | 55.0% | 54.0% | 54.2% | 56.9% | 54.7% | 54.8% | 52.4% | 52.6% | 53.9% | 56.3% | 53.7% | 54.8% | 52.9% | 55.5% | 54.6% | 56.7% | 58.3% | 55.1% | 56.1% | 58.6% | 54.7% | 57.5% | 57.3% | 54.9% | 54.4% | 53.5% | 53.2% | 53.1% | 53.7% | 53.4% | 55.6% | 54.8% | 51.2% | 52.3% | 53.0% | 52.6% | 49.8% | 52.3% | 53.1% | 51.9% | |
| 9.8% | 10.1% | 9.9% | 12.4% | 11.5% | 12.4% | 9.0% | 8.2% | 9.0% | 8.6% | 8.6% | 8.8% | 8.6% | 9.1% | 8.6% | 9.7% | 9.2% | 8.3% | 10.2% | 8.9% | 8.6% | 9.5% | 8.5% | 9.7% | 10.3% | 9.1% | 11.1% | 9.5% | 6.9% | 9.1% | 10.5% | 9.3% | 14.0% | 11.9% | 12.6% | 9.3% | 10.9% | 9.5% | 10.6% | 9.4% | 10.1% | |
| 39.6% | 38.5% | 39.0% | 42.2% | 36.8% | 32.9% | 37.9% | 36.5% | 36.9% | 34.7% | 37.5% | 35.1% | 36.0% | 34.3% | 33.9% | 35.3% | 30.6% | 24.5% | 31.1% | 29.8% | 28.3% | 30.6% | 28.2% | 30.2% | 30.3% | 28.8% | 33.3% | 30.5% | 31.8% | 30.4% | 35.2% | 30.5% | 30.8% | 30.6% | 35.7% | 31.9% | 31.7% | 31.9% | 35.9% | 32.6% | 32.9% | |
| 49.4% | 48.6% | 48.9% | 54.6% | 48.3% | 45.3% | 46.9% | 44.8% | 45.9% | 43.3% | 46.1% | 43.9% | 44.5% | 43.4% | 42.5% | 44.9% | 39.8% | 36.1% | 41.2% | 38.7% | 37.6% | 40.1% | 36.6% | 39.9% | 41.3% | 38.1% | 44.4% | 40.1% | 38.7% | 39.4% | 44.9% | 39.7% | 44.9% | 42.5% | 48.2% | 41.2% | 42.6% | 40.7% | 46.5% | 42.0% | 42.8% | |
| 5.5% | -4.1% | 5.1% | -0.5% | 8.7% | 9.4% | 7.9% | 7.6% | 6.7% | 10.6% | 10.2% | 9.8% | 10.2% | 9.5% | 13.0% | 9.6% | 16.9% | 22.2% | 13.9% | 17.4% | 21.0% | 14.6% | 20.9% | 17.4% | 13.6% | 16.2% | 9.1% | 13.2% | 14.4% | 14.4% | 8.5% | 15.9% | 9.9% | 8.7% | 4.0% | 11.8% | 10.2% | 8.9% | 5.8% | 11.2% | 9.1% | |
| 1.1% | 0.9% | 1.1% | 1.2% | 1.1% | 0.9% | 1.0% | 1.0% | 1.1% | 1.0% | 1.1% | 1.0% | 1.0% | 1.0% | 1.0% | 1.1% | 0.9% | 0.6% | 0.1% | 0.1% | 0.1% | 0.0% | 0.6% | 1.6% | 1.7% | 1.6% | 1.8% | 1.8% | 2.0% | 1.8% | 2.0% | 1.9% | 1.9% | 1.8% | 2.0% | 1.9% | 1.9% | 1.7% | 2.1% | 1.9% | 1.9% | |
| 4.5% | -4.9% | 4.0% | 0.2% | 7.3% | 6.1% | 156.6% | 59.1% | 64.2% | -168.8% | 203.5% | 134.4% | -59.8% | 112.0% | 157.2% | 232.1% | 260.2% | 136.6% | 178.5% | 161.6% | 672.3% | -278.1% | -623.9% | -176.9% | -30.7% | 149.4% | 12.5% | -220.3% | 21.7% | 62.9% | 80.4% | -436.4% | 132.6% | -136.2% | 14.2% | 63.5% | -66.0% | 134.0% | -116.5% | 83.3% | 13.5% | |
| 0.8% | -1.3% | 1.5% | -0.8% | 2.1% | -6.4% | 37.5% | 12.5% | 14.8% | -34.5% | 47.3% | 29.8% | -13.6% | 23.4% | 37.2% | 52.1% | 57.1% | 30.3% | 44.0% | 33.9% | 146.5% | -63.4% | -142.9% | -42.8% | -6.6% | 36.1% | 2.3% | -49.7% | 4.9% | 11.6% | 17.5% | -97.2% | 32.1% | -28.9% | 3.3% | 14.8% | -13.7% | 30.2% | -27.5% | 26.2% | 4.9% | |
| 3.6% | -3.6% | 2.5% | 1.0% | 5.1% | 12.5% | 119.1% | 46.5% | 49.4% | -134.3% | 156.2% | 104.6% | -46.2% | 88.6% | 120.0% | 180.0% | 203.1% | 106.2% | 134.5% | 127.7% | 525.8% | -214.8% | -481.0% | -134.2% | -24.1% | 114.1% | 10.2% | -170.6% | 16.8% | 51.3% | 62.9% | -339.2% | 100.5% | -107.2% | 10.9% | 48.8% | -52.4% | 103.9% | -89.0% | 57.1% | 8.6% | |
| 13.1% | 1.7% | 11.8% | 8.7% | 14.9% | 16.3% | 163.9% | 66.1% | 71.7% | 16.2% | 212.3% | 142.9% | -50.8% | 113.5% | 164.1% | 239.6% | 266.3% | 141.7% | 184.4% | 167.7% | 678.1% | -273.5% | -618.6% | -169.2% | -23.7% | 157.9% | 21.1% | -210.0% | 31.3% | 72.5% | 90.2% | -427.2% | 142.0% | -127.0% | 22.8% | 73.2% | -57.4% | 141.9% | -107.5% | 83.3% | 19.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.